CINT CI&T Inc

NYSE ciandt.com


$ 4.22 $ -0.04 (-0.94 %)    

Wednesday, 15-Oct-2025 13:31:23 EDT
QQQ $ 598.20 $ -5.62 (-0.93 %)
DIA $ 461.56 $ -3.08 (-0.66 %)
SPY $ 661.17 $ -5.62 (-0.84 %)
TLT $ 90.49 $ -0.45 (-0.49 %)
GLD $ 385.47 $ -0.50 (-0.13 %)
$ 4.22
$ 4.27
$ 4.20 x 1
$ 4.24 x 5
$ 4.21 - $ 4.28
$ 3.98 - $ 8.00
293,469
na
94.94M
$ 1.42
$ 3.22
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cit-expects-fy-2025-revenue-to-rise-105-150-yoy

CI&T (NYSE:CINT) expects FY 2025 revenue to rise 10.5%-15.0% YoY

 cit-q3--revenue-expected-to-be-more-than-124400m-vs-123662m-est

CI&T (NYSE:CINT) Q3 Revenue expected to be more than $124.400M vs $123.662M Est

 cit-q2-adj-eps-009-inline-sales-117200m-beat-117058m-estimate

CI&T (NYSE:CINT) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is unchanged...

 where-cit-stands-with-analysts
Where CI&T Stands With Analysts
07/22/2025 22:00:21

 ubs-maintains-neutral-on-cit-lowers-price-target-to-68

UBS analyst Leonardo Olmos maintains CI&T (NYSE:CINT) with a Neutral and lowers the price target from $8 to $6.8.

 jp-morgan-upgrades-cit-to-overweight-announces-7-price-target

JP Morgan analyst Puneet Jain upgrades CI&T (NYSE:CINT) from Neutral to Overweight and announces $7 price target.

 cit-q2--revenue-expected-to-be-more-than-11550m-vs-11171m-est

CI&T (NYSE:CINT) Q2 Revenue expected to be more than $115.50M vs $111.71M Est

 cit-expect-fy-2025-net-revenue-growth-at-constant-currency-
to-be-in-the-range-of-9-to-15-yoy

CI&T (NYSE:CINT) .

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION